PHILIP JOHN ROOS, M.D.
Osteopathic Medicine in Loma Linda, CA
License number
California G39270
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California MD 15863
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California MD 11957
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California G39270
Category
Osteopathic Medicine
Type
Critical Care Medicine
License number
California MD 15863
Category
Osteopathic Medicine
Type
Critical Care Medicine
License number
California MD 11957
Category
Osteopathic Medicine
Type
Critical Care Medicine
License number
California G39270
Category
Osteopathic Medicine
Type
Pulmonary Disease
License number
California MD 15863
Category
Osteopathic Medicine
Type
Pulmonary Disease
License number
California MD 11957
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
11201 Benton St Medical Service, Loma Linda, CA 92357
Phone
(909) 583-6094
Organization information
See more information about PHILIP JOHN ROOS at bizstanding.comPhilip John Roos
11201 Benton St, Loma Linda, CA 92357
Status:
Inactive
Industry:
Nonclassifiable Establishments
Professional information
Dr. Philip J Roos, Loma Linda CA - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine, Pulmonology
Address:
Jerry L Pettis VA Medical Ctr
11201 Benton St, Loma Linda 92357
(909) 825-7084 (Phone)
11201 Benton St, Loma Linda 92357
(909) 825-7084 (Phone)
Certifications:
Critical Care Medicine, 1997, Internal Medicine, 1979, Pulmonary Disease, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Jerry L Pettis VA Medical Ctr
11201 Benton St, Loma Linda 92357
Loma Linda University Medical Center
11234 Anderson St, Loma Linda 92354
11201 Benton St, Loma Linda 92357
Loma Linda University Medical Center
11234 Anderson St, Loma Linda 92354
Education:
Medical School
Loma Linda University
Graduated: 1975
U Wash Affil Hosps
University Of California-San Francisco
Loma Linda University
Graduated: 1975
U Wash Affil Hosps
University Of California-San Francisco
Philip John Roos, Loma Linda CA
Specialties:
Internal Medicine, Critical Care Medicine, Pulmonary Disease, Critical Care Medicine
Work:
Va Loma Linda Healthcare System
11201 Benton St, Loma Linda, CA 92357
11201 Benton St, Loma Linda, CA 92357
Education:
Loma Linda University (1975)
Cosmetic Or Dermatological Use Of 7-Hydroxylated Steroids In Combination With Elastin Derived Peptides
US Patent:
6777389, Aug 17, 2004
Filed:
Nov 19, 1999
Appl. No.:
09/443631
Inventors:
Thomas F. Mitts - Visalia CA
Lawrence B. Sandberg - Murrieta CA
Philip J. Roos - Loma Linda CA
Lawrence B. Sandberg - Murrieta CA
Philip J. Roos - Loma Linda CA
Assignee:
Connective Tissue Imagineering LLC - Visalia CA
International Classification:
A61K 3800
US Classification:
514 16, 514 17, 514 18, 514 2, 514182, 514177, 514178, 424401
Abstract:
The present invention is directed to a composition and method for enhancing the appearance of skin or tissue. The invention is preferably a combination of elastin-derived peptides and steroidal compounds useful in the treatment of problems associated with deficient elastin or conditions that would benefit from increased elastin.
Elastin Derived Composition And Method Of Using Same
US Patent:
6069129, May 30, 2000
Filed:
Mar 13, 1998
Appl. No.:
9/039308
Inventors:
Lawrence B. Sandberg - Colton CA
Philip J. Roos - Loma Linda CA
Thomas F. Mitts - Visalia CA
Philip J. Roos - Loma Linda CA
Thomas F. Mitts - Visalia CA
Assignee:
MRS, LLC - Visalia CA
International Classification:
A61K 3801, A61K 3808
US Classification:
514 16
Abstract:
The present invention is directed to a formulation or composition which is used to enhance the softness, elastin, or appearance of tissue by increasing the endogenous elastin production. Specifically, the present invention is directed to a composition formulated from the products of thermolysin digestion which are filtered through a 10,000 molecular weight cutoff device, which may be dried to have a formulation which contains 90% or greater of peptides having a molecular weight lower than 10,000 Da. This formulation is preferably applied to human skin in a cosmetic or therapeutic formulation and results in enhanced elasticity of the skin.